Introducing a New
Non-Opioid Solution
for Managing Pain
in Chronic Wounds
Innovative Product Development
to Improve Quality of Life
LATEST NEWS
MilanaPharm Receives Notice of Allowance from U.S. Patent Office For Lidocaine Topical Formulation
(GLOBE NEWSWIRE) -- MilanaPharm, a specialty pharmaceutical company focused on the development of innovative, non-opioid pharmaceutical solutions for wound management and pain, announced today that it received a Notice of Allowance from the United States Patent and...
Daré Bioscience, Inc. Announces Licensing and Global Rights to Novel Phase III Product Candidate for the Treatment of Bacterial Vaginosis
(GLOBE NEWSWIRE) -- Daré Bioscience, Inc.(NASDAQ: DARE), a leader in clinical-stage women’s health innovation, today announced that it has entered into definitive agreements with Hammock Pharmaceuticals, Inc., TriLogic Pharma LLC and MilanaPharm LLC under which Daré...